Detalhe da pesquisa
1.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31101627
2.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061295
3.
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Lancet Oncol
; 18(4): 454-463, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236583
4.
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.
Blood
; 120(7): 1470-2, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22786877
5.
Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.
BMC Cancer
; 14: 728, 2014 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25266049
6.
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
N Engl J Med
; 363(7): 640-52, 2010 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20818855
7.
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
Haematologica
; 97(7): 1085-91, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315486
8.
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
Blood
; 112(10): 3989-94, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18757777
9.
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02).
Onkologie
; 33(5): 222-8, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20502056
10.
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.
Blood Adv
; 4(23): 5951-5957, 2020 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275769
11.
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.
Blood Adv
; 4(15): 3699-3707, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777066
12.
In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study.
Eur J Nucl Med Mol Imaging
; 36(9): 1443-52, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19350237
13.
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
J Clin Oncol
; 37(31): 2835-2845, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31498753
14.
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data.
J Clin Lipidol
; 12(2): 464-480.e3, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310991
15.
Diagnosis and treatment of follicular lymphoma: an update.
Swiss Med Wkly
; 148: w14635, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30044476
16.
Autoimmunity and malignancy in hematology--more than an association.
Crit Rev Oncol Hematol
; 63(2): 100-10, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17391977
17.
Haemolytic anaemia and abdominal pain--a cause not to be missed.
Br J Clin Pharmacol
; 72(1): 168-9, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21235618
18.
[Lymphomas]. / Lymphome.
Praxis (Bern 1994)
; 105(1): 47-52, 2016 Jan 06.
Artigo
em Alemão
| MEDLINE | ID: mdl-26732717
19.
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
J Clin Oncol
; 34(5): 495-500, 2016 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712227
20.
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study.
Leuk Lymphoma
; 44(1): 133-8, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12691153